drugset

drugset / Trial / NCT00063752

Safety Study of PI-0824 to Treat Pemphigus Vulgaris

NCT00063752 ↗

Phase 1 Completed 15 enrolled Peptimmune

Non-randomizedOpen-labelTreatment

Summary

The purpose of this study is to determine if the use of PI-0824 in patients with Pemphigus vulgaris is safe.

Timeline

Start: 2003-07
Primary completion: —
Completion: 2005-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PI-0824	Unknown	—	—

Indications